美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Metsera Inc.

19.57

+2.0211.51%

盘后：19.620.0500+0.26%19:52 EDT

成交量：130.44万

成交额：2,490.87万

市值：20.56亿

市盈率：-1.35

高：19.64

开：17.51

低：17.34

收：17.55

数据加载中...

总览公司新闻公告

Nucana Plc盘中异动急速上涨5.31%

Metsera, Inc.2024财年实现净利润-2.09亿美元，同比减少342.70%

嗡嗡声--美国股票走势-Maze Therapeutics、UFP Technologies、Itron

嗡嗡声--美国股票走势-礼来、Krispy Kreme、贝宝

Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。

嗡嗡声--美国股票走势-Zoom Communications、Home Depot、Civitas Resources

BUZZ-美银美林以 "买入 "评级开始覆盖减肥药开发商 Metsera

热闹的“2025减肥药第一股”，不属于我们

异动解读 | Metsera在纳斯达克成功上市筹资2.75亿美元股价盘中大涨41.67%

医疗IPO活跃，今晚Metsera和Maze上市

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MTSR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":19.57,"timestamp":1744920000000,"preClose":17.55,"halted":0,"volume":1304388,"hourTrading":{"tag":"盘后","latestPrice":19.62,"preClose":19.57,"latestTime":"19:52 EDT","volume":4051,"amount":79275.9251,"timestamp":1744933941686},"delay":0,"floatShares":59968852,"shares":105050219,"eps":-14.490661,"marketStatus":"休市中","change":2.02,"latestTime":"04-17 16:00:00 EDT","open":17.51,"high":19.64,"low":17.34,"amount":24908684.55516,"amplitude":0.131054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.490661,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":17.55,"preHourTrading":{"tag":"盘前","latestPrice":17.5,"preClose":17.55,"latestTime":"09:29 EDT","volume":895,"amount":16010.970935,"timestamp":1744896599999},"postHourTrading":{"tag":"盘后","latestPrice":19.62,"preClose":19.57,"latestTime":"19:52 EDT","volume":4051,"amount":79275.9251,"timestamp":1744933941686},"volumeRatio":0.8982190805115574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":59968852,"roa":"-27.09%","roe":"-108.40%","lyrEps":-14.490661,"volumeRatio":0.8982190805115574,"shares":105050219,"dividePrice":0,"high":19.64,"amplitude":0.131054,"preClose":17.55,"low":17.34,"week52Low":12.3,"pbRate":"-8.11","week52High":32.8082,"institutionHeld":0,"latestPrice":19.57,"eps":-14.490661,"divideRate":0,"volume":1304388,"delay":0,"ttmEps":-14.490661,"open":17.51,"prevYearClose":18,"prevWeekClose":14,"prevMonthClose":27.22,"prevQuarterClose":27.22,"fiveDayClose":13.08,"twentyDayClose":27.82,"sixtyDayClose":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527160001","title":"Nucana Plc盘中异动 急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527160001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527160001?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 22:13","pubTimestamp":1744640000,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时13分，Nucana Plc股票出现波动，股价快速拉升5.31%。Nucana Plc股票所在的生物技术行业中，整体涨幅为1.35%。Nucana Plc公司简介：NuCana PLC是一家生物制药公司，专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药，旨在克服关键的抗癌机制，并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221321aa2c6e80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221321aa2c6e80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTSR","NCNA"],"gpt_icon":0},{"id":"2522519620","title":"Metsera, Inc.2024财年实现净利润-2.09亿美元，同比减少342.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522519620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522519620?lang=zh_cn&edition=fundamental","pubTime":"2025-03-28 15:00","pubTimestamp":1743145230,"startTime":"0","endTime":"0","summary":"3月28日，Metsera, Inc.公布财报，公告显示公司2024财年净利润为-2.09亿美元，同比减少342.70%；其中营业收入为0.00美元，每股基本收益为-14.49美元。从资产负债表来看，Metsera, Inc.总负债1.64亿美元，其中短期债务9.49百万美元，资产负债比为2.82，流动比率为0.06。机构评级：截至2025年3月28日，当前有2家机构对Metsera, Inc.目标价做出预测，其中目标均价为47.00美元，其中最低目标价为38.00美元，最高目标价为56.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328150032a6a70ec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328150032a6a70ec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTSR"],"gpt_icon":0},{"id":"2514904306","title":"嗡嗡声--美国股票走势-Maze Therapeutics、UFP Technologies、Itron","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904306","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904306?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 03:44","pubTimestamp":1740512663,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.11%，报43,508.59点。标准普尔500指数.SPX下跌0.55%，报5950.58点；纳斯达克综合指数.IXIC下跌1.25%，报19045.13点。标准普尔 500 指数.PG.INX涨幅前三名是： ** Solventum Corp SOLV.N，上涨 10.4. ** Concord Medical Services Holdings Ltd CCM.N，上涨 15.7. 纳斯达克.PL.O百分比跌幅前三名： ** Transcode Therapeutics Inc RNAZ.OQ，下跌 42.5. ** Connexa Sports Technologies Inc YYAI.OQ，跌幅 40.9** Li Auto Inc LI.O，下跌 40.9%：。BUZZ - 美国银行开始对减肥药开发商Metsera进行评级，给予 \"买入 \"评级  nL3N3PG101. BUZZ - 美国银行开始对胰岛素设备制造商 Beta Bionics 进行 \"买入 \"评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG1YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","NVIW.SI","EVER","IART","STRK","CSCO","CAKE","NVDU","ADIL","AHCO","NVDX","LVTX","HRMY","BBIO","ITRI","2NVD.UK","PODD","RETO","DOMH","SNVD.UK","NVD2.UK","TSYW.SI","MAZE","AXGN","NVDD","HSIC","ONVO","NVD3.UK","DNUT","NVDY","UFPT","MTSR","TNDM","GSHD","NVDS.UK","BGC","KDP","NTRA","PTLO"],"gpt_icon":1},{"id":"2514156097","title":"嗡嗡声--美国股票走势-礼来、Krispy Kreme、贝宝","url":"https://stock-news.laohu8.com/highlight/detail?id=2514156097","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514156097?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:30","pubTimestamp":1740493809,"startTime":"0","endTime":"0","summary":"nL3N3PG0XA ** JOYY Inc YY.O:BUZZ - 因百度收购该公司直播业务交易而上涨   nL3N3PG0YU ** Hims & Hers Health Inc HIMS.N:BUZZ - 因警告可能停止复方制剂Wegovy而下滑。nL3N3PG0XL ** Amer Sports Inc AS.N:BUZZ - 因年度预测大幅低于预期而下滑   nL3N3PG0ZA ** Unity Software U.N：BUZZ - 在6亿美元可转换交易定价后下滑  nL6N3PG0HC ** Civitas Resources Inc CIVI.N:BUZZ - 因第四季度利润不及预期而下跌    nL3N3PG10V ** Metsera Inc MTSR.O:BUZZ - 美国银行以 \"买入 \"评级开始覆盖减肥药开发商Metsera。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG1DP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","LLY","CAKE","PLNT","CHGG","PYPL","89888","DNUT","NVDS","HD","SNVD.UK","02020","BBNX","CLF","AU","NTRA","IART","MTSR","PTLO","NIO.SI","EVER","82020","SRE","HRMY","NEM","ONVO","DOMH","BKSY","ZM","CIVI","NVIW.SI","YY","KDP","AS"],"gpt_icon":1},{"id":"2514097940","title":"Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097940","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514097940?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:22","pubTimestamp":1740493354,"startTime":"0","endTime":"0","summary":"Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25222248383565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MTSR"],"gpt_icon":0},{"id":"2514209339","title":"嗡嗡声--美国股票走势-Zoom Communications、Home Depot、Civitas Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2514209339","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514209339?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:10","pubTimestamp":1740485430,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG128:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["82020","ANPDY","NVDS","NVDX","MTSR","CIVI","LU0456827905.SGD","ZM","2NVD.UK","SNVD.UK","AS","NIO.SI","YY","LU0494093205.USD","HD","EVER","IE00B19Z9505.USD","EVS.SI","NVDD","NVD","LU1162221912.USD","NVDY","NVD3.UK","LU1718418525.SGD","02020","LU0127658192.USD","LU0640476718.USD","NVD2.UK","89888","NVIW.SI","3NVD.UK","LU1242518931.SGD","NVDU","DOMH","NVDS.UK"],"gpt_icon":1},{"id":"2514060714","title":"BUZZ-美银美林以 \"买入 \"评级开始覆盖减肥药开发商 Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060714","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060714?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:49","pubTimestamp":1740484170,"startTime":"0","endTime":"0","summary":"BUZZ-美银美林以 \"买入 \"评级开始覆盖减肥药开发商 Metsera2月25日 -  ** 博雅全球研究公司开始对减肥药开发商Metsera MTSR.O进行评级，给予 \"买入 \"评级，目标价为38美元。** MTSR 的口服肽 MET-224o 的 \"生物利用率 \"可能比目前获批的口服肽诺和诺德的NOVOb.CO Rybelsus 高 5-6 倍。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG10N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAC","MTSR"],"gpt_icon":0},{"id":"2511567929","title":"热闹的“2025减肥药第一股”，不属于我们","url":"https://stock-news.laohu8.com/highlight/detail?id=2511567929","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511567929?lang=zh_cn&edition=fundamental","pubTime":"2025-02-13 13:54","pubTimestamp":1739426077,"startTime":"0","endTime":"0","summary":"2025年，美股第一家上市的减肥药biotech涨疯了。1月31日，Metsera上市首日，股价涨幅达到47.22%。在接下来的7个交易日里，股价继续上涨，最新市值已经突破30亿美元。而这一切，距离Metsera创立的2022年，不过3年时间。对于国内外众多押注GLP-1的biotech来说，这无疑也是他们梦寐以求的。公司的定位是“彻底改变肥胖治疗”，其核心布局分为两大类。所以，Metsera认为，MET-097i的给药周期，能延长至1个月1次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/250698","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06978","MTSR","BK4139","BK1191","01477","BK1574","BK1161"],"gpt_icon":0},{"id":"1191771744","title":"异动解读 | Metsera在纳斯达克成功上市 筹资2.75亿美元 股价盘中大涨41.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191771744","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191771744?lang=zh_cn&edition=fundamental","pubTime":"2025-02-01 01:36","pubTimestamp":1738344987,"startTime":"0","endTime":"0","summary":"在医疗行业IPO活跃的大环境下,Metsera Inc. 于今日在美国纳斯达克成功上市,公司股价盘中大涨41.67%,引起了市场广泛关注。据报道,Metsera是一家临床阶段的生物技术公司,正在开发基于GLP-1机制和其他生物靶点的注射和口服药物来治疗肥胖症及相关疾病。在此次IPO中,公司以每股18美元的发行价共发行了1528万股,募资总额高达2.75亿美元。以发行价计算,Metsera的估值约为18.5亿美元。IPO后,这些机构将继续持有Metsera股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Metsera在纳斯达克成功上市 筹资2.75亿美元 股价盘中大涨41.67%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MTSR"],"gpt_icon":0},{"id":"2507331069","title":"医疗IPO活跃，今晚Metsera和Maze上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2507331069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507331069?lang=zh_cn&edition=fundamental","pubTime":"2025-01-31 15:40","pubTimestamp":1738309211,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Metsera和Maze Therapeutics这两家制药商在周四公布了首次公开募股定价。根据一份声明，Metsera IPO定价为每股18美元，该公司将出售1530万股股票以筹资2.75亿美元。资料显示，Metsera是一家位于临床阶段的生物技术公司，开发治疗肥胖及相关疾病的注射和口服药物。该公司的最大股东是Third Rock Ventures的子公司，其他投资者包括ARCH Venture Partners的子公司等。在这个1月，Beta Bionics周三进行了2.04亿美元的IPO，亚盛医药于1月23日发行了1.26亿美元的美国存托股票。","market":"us","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245141.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MAZE","MTSR","159891"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-04-17","current":-8.815846,"percent":0.857143,"low":-55.8522,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"high":-6.570442,"avg":-15.990528,"sd":6.909743,"marketCap":1843631343},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343}],"updateTime":1745099052593}}}